These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24926516)

  • 21. Appetite suppressant was probably responsible for 1300 deaths, study shows.
    Benkimoun P
    BMJ; 2012 Feb; 344():e996. PubMed ID: 22323511
    [No Abstract]   [Full Text] [Related]  

  • 22. [The French are wary of their drugs].
    Nau JY
    Rev Med Suisse; 2011 May; 7(296):1170-1. PubMed ID: 21728251
    [No Abstract]   [Full Text] [Related]  

  • 23. Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease.
    Boudes A; Lavoute C; Avierinos JF; Le Dolley Y; Villacampa C; Salem A; Loundou AD; Michel N; Renard S; Habib G
    Eur J Echocardiogr; 2011 Sep; 12(9):688-95. PubMed ID: 21810827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenfluramine-like cardiovascular side-effects of benfluorex.
    Boutet K; Frachon I; Jobic Y; Gut-Gobert C; Leroyer C; Carlhant-Kowalski D; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2009 Mar; 33(3):684-8. PubMed ID: 19251806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fen-phen and risk of valvular disease.
    SoRelle R
    Circulation; 1997 Sep; 96(6):1705-6. PubMed ID: 9323046
    [No Abstract]   [Full Text] [Related]  

  • 26. From the Centers for Disease Control and Prevention. Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: US Department of Health and Human Services interim public health recommendations, November 1997.
    JAMA; 1997 Dec; 278(21):1729-31. PubMed ID: 9388136
    [No Abstract]   [Full Text] [Related]  

  • 27. Anorectic therapy and valvular heart disease: a reappraisal.
    Silvestry FE; St John Sutton M
    Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
    [No Abstract]   [Full Text] [Related]  

  • 28. The fen-phen controversy: is regression another piece of the puzzle?
    Asinger RW
    Mayo Clin Proc; 1999 Dec; 74(12):1302-4. PubMed ID: 10593359
    [No Abstract]   [Full Text] [Related]  

  • 29. How can benfluorex-related heart valve disease be identified by echocardiography?
    Tribouilloy C; Rusinaru D; Andréjak M
    Arch Cardiovasc Dis; 2011 Oct; 104(10):489-92. PubMed ID: 22044700
    [No Abstract]   [Full Text] [Related]  

  • 30. Mediator scandal rocks French medical community.
    Mullard A
    Lancet; 2011 Mar; 377(9769):890-2. PubMed ID: 21409784
    [No Abstract]   [Full Text] [Related]  

  • 31. Valvular heart disease associated with fenfluramine-phentermine.
    Kurz X; Van Ermen A
    N Engl J Med; 1997 Dec; 337(24):1772-3; author reply 1775. PubMed ID: 9411247
    [No Abstract]   [Full Text] [Related]  

  • 32. Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report.
    Baufreton C; Bruneval P; Rousselet MC; Ennezat PV; Fouquet O; Giraud R; Banfi C
    Medicine (Baltimore); 2017 Jan; 96(2):e4985. PubMed ID: 28079786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Food and Drug Administration criteria for the diagnosis of drug-induced valvular heart disease in patients previously exposed to benfluorex: a prospective multicentre study.
    Maréchaux S; Rusinaru D; Jobic Y; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Garban T; Ennezat PV; Jeu A; Szymanski C; Tribouilloy C
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):158-65. PubMed ID: 25368209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anorectic drugs and valvular heart disease.
    Krynicki PF
    Cleve Clin J Med; 1998 May; 65(5):277; author reply 277-8. PubMed ID: 9599914
    [No Abstract]   [Full Text] [Related]  

  • 35. Appetite suppressants and valvular heart disease.
    Devereux RB
    N Engl J Med; 1998 Sep; 339(11):765-6. PubMed ID: 9731094
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased risk of left heart valve regurgitation associated with benfluorex use in patients with diabetes mellitus: a multicenter study.
    Tribouilloy C; Rusinaru D; Maréchaux S; Jeu A; Ederhy S; Donal E; Réant P; Arnalsteen E; Boulanger J; Ennezat PV; Garban T; Jobic Y
    Circulation; 2012 Dec; 126(24):2852-8. PubMed ID: 23143159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benfluorex: An active toxin for the development of aortic valve stenosis.
    Melloul E; Bruneval P; Chavanon O; Lantuejoul S; Augier C; Salvat M; Maréchaux S; Tribouilloy C; Assoun B; Ennezat PV
    Int J Cardiol; 2015 Feb; 181():328-30. PubMed ID: 25544201
    [No Abstract]   [Full Text] [Related]  

  • 38. Valvular heart disease associated with fenfluramine-phentermine.
    Wolff FW
    N Engl J Med; 1997 Dec; 337(24):1774; author reply 1775-6. PubMed ID: 9411250
    [No Abstract]   [Full Text] [Related]  

  • 39. Risks of heart-valve abnormalities with appetite suppressants.
    Baird IM
    Lancet; 1998 Oct; 352(9138):1403-4. PubMed ID: 9807983
    [No Abstract]   [Full Text] [Related]  

  • 40. Appetite-suppressant drugs and valvular heart disease.
    Williamson DF; Yanovski SZ
    N Engl J Med; 1999 Feb; 340(6):476; author reply 478-80. PubMed ID: 9988618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.